(Q42557959)

English

Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group

scientific article published on June 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group (English)

1 reference

Europe PubMed Central

2 November 2017

multicenter clinical trial

0 references

author name string

T D Ruddy

1

1 reference

Europe PubMed Central

2 November 2017

J M Wright

2

1 reference

Europe PubMed Central

2 November 2017

D Savard

3

1 reference

Europe PubMed Central

2 November 2017

S P Handa

4

1 reference

Europe PubMed Central

2 November 2017

A Chockalingam

5

1 reference

Europe PubMed Central

2 November 2017

A P Boulet

6

1 reference

Europe PubMed Central

2 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 1995

1 reference

Europe PubMed Central

2 November 2017

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

2 November 2017

9

1 reference

Europe PubMed Central

2 November 2017

3

1 reference

Europe PubMed Central

2 November 2017

413-420

1 reference

Europe PubMed Central

2 November 2017

The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive therapy and lipids. Evidence, mechanisms, and implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium antagonists for initial therapy of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How often is medication taken as prescribed? A novel assessment technique

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

24-hour efficacy of once-daily diltiazem in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of diltiazem and atenolol in young, physically active men with essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of antihypertensive drugs on serum lipids and lipoproteins, I. Diuretics

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of calcium antagonists as initial pharmacologic monotherapy for systemic hypertension in patients over 60 years of age.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood pressure, stroke, and coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dose-response trial of once-daily diltiazem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained-release diltiazem: duration of antihypertensive effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diltiazem and propranolol in mild to moderate essential hypertension as monotherapy or with hydrochlorothiazide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive and metabolic effects of diltiazem and nifedipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diltiazem. A review of its pharmacological properties and therapeutic efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium antagonists in geriatric patients: diltiazem in elderly persons with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic effects of antihypertensive therapy with a calcium antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/8527351

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00879030

1 reference

Europe PubMed Central

2 November 2017

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42557959&oldid=1961513683"